Lactase and Lactose Intolerance — Does Enzyme Supplementation Really Help?

Lactose intolerance is one of the most common digestive complaints worldwide — depending on the population and ethnic background, estimates range from a little over ten percent to more than 70% of adults. Bloating, gas, abdominal cramps, and diarrhea after a glass of milk or a scoop of ice cream are common enough that many people eliminate dairy from their diet on their own for years before ever discussing symptoms with a doctor.

Unlike many digestive supplements whose action relies on indirect, hard-to-verify mechanisms, lactase tablets have an unusually simple and direct mechanism: they supply exactly the enzyme the body is lacking, from an external source. That makes this intervention relatively easy to test in a rigorous clinical trial — and that's exactly what a team of researchers from India did, publishing their results in JGH Open in 2020.

Lactose — the main sugar found in milk and dairy products — is a disaccharide made of glucose and galactose. To be absorbed in the small intestine, it must first be broken down into these two simple sugars by the enzyme lactase, produced by the epithelial cells lining the brush border of the small intestine. In most mammals, including humans, lactase activity is naturally high in infancy and gradually declines after weaning — a phenomenon known as primary (genetically programmed) lactase decline, present in most human populations except in groups where a mutation preserving lactose digestion into adulthood evolved over millennia.

When lactase is deficient or insufficient, undigested lactose isn't absorbed in the small intestine and passes on into the large intestine. There, gut bacteria colonizing the colon ferment it, producing among other things hydrogen, carbon dioxide, and short-chain fatty acids — a process that also draws water into the intestinal lumen osmotically. The result of this fermentation and fluid shift is the typical symptom set: bloating, gas, abdominal pain, and diarrhea, usually appearing anywhere from 30 minutes to a few hours after consuming a dairy product. This same bacterial fermentation mechanism underlies the hydrogen breath test used in the trial described below — we cover the broader role of gut bacteria in digestion in more depth in our article on the gut microbiome.

To reliably assess whether lactase supplementation genuinely helps rather than merely working through a placebo effect, a randomized, blinded, placebo-controlled trial is needed — ideally in a crossover design, where every participant goes through both interventions, allowing comparisons within the same person rather than only between different groups. That's exactly the design used in the Baijal and Tandon trial.

The trial's crossover design (each participant received both lactase and placebo, in random order, separated by a one-week washout) is a methodologically strong choice with a relatively small study group — it controls for individual differences between patients, since each person serves as their own control. This partly compensates for the limitation of the small sample size (47 people) compared with large population-based studies.

In other words: if only the subjective symptom scores had improved, one might suspect the effect was mainly driven by participant expectations. But since the objectively measurable breath hydrogen level dropped in parallel — an indicator independent of what the patient believes about the tablet they're taking — the result is harder to explain away with placebo alone. This is a good example of why pairing a subjective measure with an objective one makes for a stronger study design than relying on either alone.

This distinction has practical significance: someone with a milk protein allergy who reaches for lactase tablets thinking it will solve their problem may put themselves at risk of an allergic reaction, since the dairy product will still contain the sensitizing protein. If symptoms after dairy are severe, atypical (e.g., rash, swelling, shortness of breath), or appear very quickly after consumption, it's worth considering an allergy consultation rather than assuming it's "just" lactose intolerance.

It's worth emphasizing that lactase supplementation isn't the only, nor always the necessary, strategy for managing lactose intolerance. Many people with mild intolerance tolerate small amounts of dairy spread throughout the day well, along with aged cheeses (naturally low in lactose) or fermented products, in which some of the lactose has already been broken down by fermentation bacteria — this is, incidentally, another example of how microorganisms affect the digestibility of food, a topic we cover more broadly in our article on the gut microbiome. Lactase supplementation is most useful precisely where these natural strategies fall short — when consuming larger amounts of full-fat dairy, such as ice cream or a large glass of milk.

Lactase supplementation is one of the rare examples of a digestive supplement with a fully understood, direct mechanism of action, confirmed in a trial that paired subjective symptom assessment with an objective physiological measurement. This isn't a claim that it will help everyone in every situation — the severity of lactase deficiency is individual, and the trial comes from a single, relatively small center. It is, however, a solid, rational option for people with confirmed lactose intolerance who want to occasionally enjoy dairy without predictable digestive discomfort.